Related Experiment Video

Updated: Mar 2, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.2K

Body Mass Index, Quality of Life, and Catheter Ablation in Patients with Atrial Fibrillation

Ethan R Ellis1, Matthew R Reynolds2

  • 1Beth Israel Deaconess Medical Center.

Journal of Atrial Fibrillation
|May 13, 2017
PubMed

Insights

Obesity and atrial fibrillation (AF) negatively impact quality of life. Catheter ablation may improve quality of life for obese patients with AF, an area needing further research.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Atrial fibrillation (AF) and obesity are prevalent, interconnected conditions impacting patient quality of life.
  • The co-occurrence of AF and obesity is increasing, leading to more obese patients undergoing AF treatments.
  • Quality of life is a crucial outcome measure for patients with AF.

Purpose of the Study:

  • To review the impact of atrial fibrillation and obesity on quality of life.
  • To examine the effects of catheter ablation on quality of life in obese patients with AF.

Main Methods:

  • Literature review of studies on AF, obesity, quality of life, and catheter ablation outcomes.
  • Synthesis of existing data regarding quality of life improvements post-ablation in obese populations.

Main Results:

  • Both AF and obesity independently diminish quality of life.
  • Evidence suggests catheter ablation improves quality of life in general AF populations.
  • Limited data currently exists on quality of life outcomes specifically for obese AF patients undergoing ablation.

Conclusions:

  • Obesity presents unique challenges and considerations for AF management and quality of life.
  • Further research is warranted to fully understand and optimize catheter ablation's benefits for obese patients with AF.

More Related Videos

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.9K
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.2K

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
547
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
907
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578